학술논문

Idelalisib immune-related toxicity is associated with improved treatment response
Document Type
Article
Source
In: Leukemia and Lymphoma. (Leukemia and Lymphoma, 2021, 62(12):2915-2920)
Subject
Language
English
ISSN
10292403
10428194